| 81 | 15 | 16 |
| 下载次数 | 被引频次 | 阅读次数 |
目的:探讨阿维A联合窄谱中波紫外线(NB-UVB)治疗寻常型银屑病的临床疗效。方法:选取我科2014年6月~2015年6月收治的50例寻常型银屑病患者作为研究对象,随机分为观察组(阿维A联合NB-UVB)和对照组(阿维A);对照组采用阿维A 10mg/次,2次/d于餐后口服;观察组在对照组的基础上联合NB-UVB进行照射治疗,时间30min/次,每周3次;两组疗程均为8周,并观察两组银屑病面积严重度指数(PASI)评分、临床治疗效果及临床症状评分。结果:随着治疗周期的延长PASI指数逐渐减低,观察组治疗2、4、8周后PASI指数明显低于对照组,两组比较,差异有统计学意义(P<0.05);治疗8周后观察组总有效率为96.00%,明显高于对照组(76.00%),差异有统计学意义(P<0.05);观察组治疗8周后红斑、瘙痒、鳞屑、浸润症状改善显著优于对照组,差异有统计学意义(P<0.05)。结论:阿维A联合NB-UVB对寻常型银屑病有协同治疗作用,可显著改善临床症状,提高临床疗效,值得进一步推广。
Abstract:Objective:To explore the clinical efficacy of acitretin in combined with narrow band ultraviolet B(NB-UVB)in the treatment of psoriasis vulgaris.Methods:A total of 50 patients with psoriasis vulgaris who were admitted in our hospital from June,2014 to June,2015 were included in the study and randomized into the observation group and the control group.The patients in the control group were given acitretin,10mg/time,P.O.after dinner,twice a day.On this basis,the patients in the observation group were given additional NB-UVB for irradiation therapy,30 min a time,three times a week.Eight-week treatment was regarded as one course.PASI scores,the clinical treatment efficacy,and the clinical symptoms in the two groups were observed.Results:With the extending of treatment cycle,PASI was gradually reduced.2,4,and 8weeks after treatment PASI scores in the observation group were significantly lower than those in the control group(P<0.05).The total effective rate was 96.00% after 8-week treatment in the observation group and was significantly superior to that in the control group with 76.00%(P<0.05).The improvements of erythema,pruritus,scales,and infiltration after 8-week treatment in the observation group were significantly superior to those in the control group(P<0.05).Conclusions:Acitretin in combined with NB-UVB in the treatment of psoriasis vulgaris can produce a synergistic effect,significantly improve the clinical symptoms,and enhance the clinical efficacy;therefore,it can be further recommended.
1刘旭星.阿维A联合窄谱中波紫外线治疗65例中重度寻常型银屑病疗效观察[J].中国药物与临床,2012,12(6):786-787.
2 罗寰,董萍云,孟凡茹,等.寻常性银屑病患者血清IL-17和IL-22检测与其PASI评分的相关性分析[J].中国皮肤病性病学杂志,2011,25(12):941-943.
3 赵娜,吴卫志,杨平,等.银屑病流行病学研究进展[J].山东医药,2013,53(39):95-97.
4 姚宏艳,高以红,高洁.寻常型银屑病患者血清白介素-21、白介素-31水平及其与病情严重程度的相关性研究[J].实用临床医药杂志,2015,19(17):71-73.
5 王琼玉,张爱军,马慧群,等.腺病毒介导的PML基因对银屑病样小鼠模型的作用[J].南方医科大学学报,2013,33(3):432-435.
6 李芳梅,杨志波.中西医结合疗法治疗银屑病临床疗效及对患者生活质量评价分析[J].河北医学,2014,20(4):532-534,535.
7 周飞红,喻雅也,李东升,等.紫外线治疗特应性皮炎的进展[J].国际皮肤性病学杂志,2013,39(1):38-41.
8 宋维旭,赵晓云,颉玉胜,等.窄谱中波紫外线治疗寻常型银屑病临床效果及细胞因子变化[J].临床误诊误治,2013,26(9):63-65.
9 张学军.皮肤性病学[M].6版,北京:人民卫生出版社,2005:129.
10 蔡莎莉,彭俊秋.PASI评分在银屑病护理观察中应用的效果评价[J].中国实用护理杂志,2013,29(z1):114.
11 胡剑白.阿维A联合窄谱UVB照射治疗寻常型银屑病的疗效观察[J].齐齐哈尔医学院学报,2014,35(14):2104-2105.
12 管青,熊志刚,李辉军.寻常型银屑病患者血清MMP-2、IL-18和IL-2的检测及临床意义[J].中国实验诊断学,2012,16(7):1183-1185.
13 韦方铨,陈洁华,吴晓红,等.阿维A联合窄谱中波紫外线治疗寻常型银屑病疗效观察[J].中国现代医生,2013,51(8):154-155.
14 靳香玲,秦凌花,靳书兰.阿维A联合窄谱中波紫外线治疗寻常性银屑病疗效观察[J].中国中西医结合皮肤性病学杂志,2010,9(5):307-308.
15 赵延明,张东,盖希余,等.阿维A联合窄谱中波紫外线治疗寻常型银屑病的临床疗效观察[J].中国现代医生,2014,52(6):68-70.
16 赵探虎.口服阿维A胶囊联合窄谱中波紫外线照射治疗寻常型银屑病的疗效观察[J].山西医药杂志,2012,41(3):287-288.
17 赵艳霞.T淋巴细胞与银屑病发病机制的关系[J].中国中西医结合皮肤性病学杂志,2010,9(6):398-400.
18 吴娟.阿维A联合窄谱UVB照射治疗寻常型银屑病的疗效观察[J].河北医药,2013,35(21):3288-3289.
19 Schneider LA,Hinrichs R,Scharffetter-Kochanek K.Phototherapy and photochemotherapy[J].Clin Dermatol,2008,26(5):464-476.
基本信息:
DOI:10.13210/j.cnki.jhmu.20151203.001
中图分类号:R758.63
引用信息:
[1]韩雪松,岳致丰,田坤,等.阿维A联合窄谱中波紫外线对寻常型银屑病疗效研究[J].海南医学院学报,2016,22(05):516-517+520.DOI:10.13210/j.cnki.jhmu.20151203.001.
基金信息:
河北省科技术研究与发展指导计划项目(0921117D)~~
2015-12-03
2015-12-03
2015-12-03